𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer

✍ Scribed by Jeong-Yeol Park; Jeong-Min Eom; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
125 KB
Volume
101
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The role of secondary cytoreductive surg
✍ Scott M. Eisenkop; Richard L. Friedman; Nick M. Spirtos πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

BACKGROUND. This study examined the impact of secondary cytoreductive surgery on survival of patients with recurrent epithelial ovarian carcinoma. ## METHODS. One hundred six patients with a disease free interval (DFI) ΟΎ 6 months after primary treatment underwent secondary cytoreductive surgery. M

Recurrent micropapillary serous ovarian
✍ Robert E. Bristow; Dana R. Gossett; David R. Shook; Mariana L. Zahurak; Rafael S πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 1 views

## Background: The objectives of the current study were to: 1) characterize the clinical outcome of patients with recurrent micropapillary serous ovarian carcinoma (mpsc) and 2) evaluate the survival impact of secondary cytoreductive surgery and other prognostic variables. ## Methods: Twenty-six

Surgery in recurrent epithelial ovarian
✍ Wen-Juan Tian; Rong Jiang; Xi Cheng; Jie Tang; Yan Xing; Rong-Yu Zang πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 1 views

## Abstract ## Aims Recent retrospective trials stated that a benefit of surgery for recurrent ovarian cancer may be limited to patients in whom a complete cytoreduction (R0) could be achieved. Most of them pointed out there was no difference in survival between residual disease of 0.1–1 cm (R1) a